STACIE BENKULA: Open Payments
NPI 1174116180 · TWIN FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 27 payments from 11 companies in 2025. Trend: 2023 $81 · 2024 $910 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $201 |
| Novo Nordisk Inc | 4 | $183 |
| Corcept Therapeutics | 3 | $51 |
| Lilly USA, LLC | 2 | $46 |
| Grifols USA, LLC | 1 | $37 |
| Exact Sciences Corporation | 1 | $23 |
| Cepheid | 1 | $23 |
| Amgen Inc. | 1 | $22 |
| Exeltis, USA Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: QULIPTA, Ozempic, VRAYLAR, Korlym, MOUNJARO, Prolastin-C Liquid, Wegovy, Cologuard Collection Kit.
Industry payments across ID — which companies pay providers there.
